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Male genital lichen sclerosus and filaggrin 
T.N. Shim, S. Brown, N.D. Francis, M Dinneen, D. Hawkins, A. Muneer, S. Minhas, I. 
McLean, C.B. Bunker 
Lichen sclerosus (LSc) is an acquired cutaneous disease of contentious aetiology.  
The majority of male cases involve the genitalia.  Amongst prior postulated 
pathogenic factors in genital (G)LSc are infection, autoimmunity and genetic and 
environmental influences.1  There is an arguement that male (M)GLSc might be 
due to chronic occluded exposure of susceptible epithelium to urine.  GLSc has 
also been associated with atopy.2 Filaggrin is a key epithelial protein expressed 
during terminal differentiation of the epidermis, forming a component of the 
epithelial barrier.  Loss-of-function mutations in gene encoding filaggrin (FLG) 
are observed in approximately 10% of Northern Europeans and have been found 
to be an important predisposing factor for atopic eczema.3,4   We hypothesised 
that a barrier defect due to FLG null mutations might contribute to the 
susceptibility of the genital epithelium (as might be caused, for example, by 
urinary irritation) in MGLSc.   
We studied 92 adult men (aged 21-81 years, mean 46 years, standard deviation = 
14) of white European ethnicity attending the Male Genital Dermatoses Clinics at
Chelsea & Westminster and University College Hospitals, London from July 2011
to December 2012.  All had clinical and histological findings consistent with the
diagnosis of MGLSc and five patients had concomitant eczema.  None of the
patients had extragenital LSc on complete cutaneous examination.  The work
was approved by the local Research Ethics Committee (09/H0706/58).
Genomic DNA was isolated from peripheral blood using the QIA-amp® DNA mini 
kit (Qiagen, Hilden, Germany).  Extracted DNA was genotyped for the four most 
prevalent European FLG null mutations (R501X, 2282del4, R2447X and S3247X). 
FLG genotyping was performed by allelic discrimination as described previously. 
Results for screening of all four mutations were obtained in 92 of the 93 samples 
(98.9%).  FLG genotype data from 300 male individuals without eczema from a 
previous study in the north of England was used as representative of a normal 
control population.    
Nine of the 92 MGLSc patients (9.8%) and 32 of the 300 cases (10.7%) had FLG 
null mutations.  There was no significant difference (p=0.81) in the prevalence of 
FLG null mutations in cases compared with controls matched by gender and 
ethnicity (Table 1).  Assuming a population prevalence of 0.1% for LSc1 this 
study had >75% power to detect an odds ratio of >2.4 with 2-sided p<0.05 
(Power calculation performed using Quanto version 1.2.4. 
http://hydra.usc.edu/gxe/). 
Our data therefore do not support the notion that MGLSc is associated with a 
filaggrin-related skin barrier defect, although the study was not adequately 
powered to exclude a moderate or weak association (odds ratio ≤2.4). There 
have been reports of other skin diseases such as actinic keratosis, melanoma and 
oral lichen planus associated with FLG mutations but this remains debatable.5 
Barrier dysfunction in GLSc may occur by other pathophysiological mechanisms, 
unrelated to filaggrin.  MGLSc deserves this attention because of the sexual and 
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urinary morbidity for which it can be responsible1 and its association with the 
morbidity and mortality of genital cancer.  Further studies of epithelial 
susceptibility factors in GLSc are warranted, and are indeed ongoing.  
 
Table 1 Results of FLG genotype analysis in male genital LSc cases and male 
population controls without eczema.  
 
 FLG wild type FLG heterozygote 
total number 
of individuals 
% with FLG 
null 
mutation  
Case, n 83  9 92 9.8% 
Control, n 268 32 300 10.7% 
Chi-square    p = 0.81 
 
Samples were screened for four FLG loss-of-function mutations. Amongst the 
cases, 3 individuals were heterozygous for R501X, 4 were heterozygous for 
2282del4 and 2 for S3247X; in the control group, 12 individuals were 
heterozygous for R501X, 12 for 2282del4, 6 for R2447X and 2 for S3247X. There 
were no homozygous or compound heterozygous individuals detected in this 
study. 
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